# Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease

> **NCT05857748** · — · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** lifitegrast

## Key facts

- **NCT ID:** NCT05857748
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-07-31
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company decision due to the transfer of ownership of the product
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05857748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05857748, "Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05857748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*